Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) reported Q3 EPS of ($0.44), $0.04 worse than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Sensei Biotherapeutics, Inc. (SNSE) click here.